1. From Mitochondria to Atherosclerosis: The Inflammation Path
   Juan M. Suárez-Rivero et al, 2021, Biomedicines CrossRef
2. NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
   Negin Parsamanesh et al, 2019, International Immunopharmacology CrossRef
3. Energy restriction, exercise and atorvastatin treatment improve endothelial dysfunction and inhibit miRNA-155 in the erectile tissue of the aged rat.
   B. Rocha et al, 2018, Nutrition & Metabolism CrossRef
4. Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: Molecular mechanisms
   Afsane Bahrami et al, 2020, Ageing Research Reviews CrossRef
5. Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism
   Karla Reichert et al, 2016, PLOS ONE CrossRef
6. Claudin-5 levels are reduced from multiple cell types in human failing hearts and are associated with mislocalization of ephrin-B1
   Sarah A. Swager et al, 2015, Cardiovascular Pathology CrossRef
7. Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly
   Hiroe Toba et al, 2019, Pharmacology & Therapeutics CrossRef
8. Atorvastatin exerts inhibitory effect on endothelial senescence in hyperlipidemic rats through a mechanism involving down-regulation of miR-21-5p/203a-3p
   Jie-Jie Zhang et al, 2018, Mechanisms of Ageing and Development CrossRef